The observations that the ill effects of p-tau can be mitigated by a small compound and by overexpressing HO-1 that is otherwise diminished in the treated cells inform new directions of Alzheimer’s disease drug discovery. This evidence concerns the gene HMOX1 and early-onset autosomal dominant Alzheimer disease.